Dolastatin 10 in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia

NCT00003693 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Leukemia
Myelodysplastic Syndromes

Interventions

DRUG: Dolastatin 10

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]